World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   119 records for 56 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingACTRN12614000969662
Phonological Treatment of Arabic-Speaking Children in Kuwait (Kuwaiti/ Gulf Area dialect)
10/09/2014
RecruitingNCT02210819
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
20/05/2014
RecruitingCTRI/2014/05/004598
Study to to evaluate the occurrence of Myeloproliferative neoplasm (a type of disease in which the bone marrow makes too many RBC, platelets, or certain WBC) & to characterize treatment patterns & burden/ symptoms of illness under routine medical practice
15-05-2014
RecruitingNCT02042144
Safety and Effectiveness of Regorafenib
20/01/2014
Not recruitingNCT02024139
Efficacy of Chewing Sugarless Gum for Reduction of Orthodontic Appliance Pain
26/12/2013
Not recruitingNCT01985607
Efficacy of a New Thickened Extensively Hydrolyzed Formula
08/11/2013
RecruitingNCT01980459
Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis
22/10/2013
RecruitingNCT01970189
The International ITP Registry
19/09/2013
RecruitingCTRI/2013/09/004004
Study to assess effectiveness of indacaterol in COPD patients in real life settings
19-09-2013
AuthorisedEUCTR2013-000322-66-DE
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-000322-66-ESA 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation08/10/2013
AuthorisedEUCTR2013-000322-66-NLA 24 month, safety and efficacy study of everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in renal transplantation13/11/2013
AuthorisedEUCTR2013-000322-66-ITNA12/08/2013
AuthorisedEUCTR2013-000322-66-PTTRANSFORM is an international 24 months study for new kidney transplant patients comparing 2 medication options (treatment choice decided by chance) to compare the effect of the drug everolimus (Certican) to mycophenolate (myfortic or Cellcept), both in combination with tacrolimus or cyclosporine28/10/2013
AuthorisedEUCTR2013-000322-66-GREfficacy and safety of concentration-controlled everolimus with reduced Calcineurin Inhibitor (CNI) exposure, compared to Mycophenylate (MPA) and stand CNI exposure in de novo kidney transplant.09/01/2014
RecruitingJPRN-JapicCTI-142416A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation04/03/2014
AuthorisedEUCTR2013-000322-66-ATA 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)28/10/2013
AuthorisedEUCTR2013-000322-66-SIA 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)04/04/2014
AuthorisedEUCTR2013-000322-66-SKAdvancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen25/09/2013
RecruitingNCT01950819Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)20/08/2013
AuthorisedEUCTR2013-000322-66-BEA 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)13/11/2013
AuthorisedEUCTR2013-000322-66-HRStudy evaluating the effect of treatment with everolimus in combination with reduced calcineurin inhibitor compared to a standard treatment in kidney transplant recipients.03/09/2014
AuthorisedEUCTR2013-000322-66-PLStudy evaluating the effect of treatment with everolimus in combination with reduced calcineurin inhibitor compared to a standard treatment in kidney transplant recipients24/06/2014
RecruitingCTRI/2014/07/004772To evaluate the graft function of everolimus and reduced Calcineurin Inhibitor versus mycophenolic acid sodium and standard Calcineurin Inhibitor in adult renal transplant recipients. 25-07-2014
07/08/2013
    
1 2 3 4 5 6
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history